Search results
Results from the WOW.Com Content Network
The Tyrer-Cuzek Risk Assessment Calculator was released in 2017 by Jack Cuzick, PhD, whose work has been funded by the Breast Cancer Research Foundation since 2011. The online questionnaire ...
Cancer slope factors (CSF) are used to estimate the risk of cancer associated with exposure to a carcinogenic or potentially carcinogenic substance. A slope factor is an upper bound, approximating a 95% confidence limit , on the increased cancer risk from a lifetime exposure to an agent by ingestion or inhalation .
Current smokers are also at risk for developing byssinosis or having complications relating to byssinosis. [ 4 ] Of the 81 byssinosis-related fatalities reported in the United States between 1990 and 1999, 48% included an occupation in the yarn, thread, and fabric industry on their death certificate. [ 6 ]
For individual men, the discriminatory accuracy [5] for colon cancer was 0.71 and for pancreatic cancer was 0.72. These values exceed the performance of many other cancer risk prediction tools. [6] [7] The approach used to calculate cancer risks in Your Disease. Risk is also used to calculate the risks of the other diseases. [8]
The result is a lifetime risk and a five-year risk based on factors that have been tied to a higher risk of breast cancer. For comparison, it also gives an average risk for U.S. women of the same ...
Lower age of first childbirth, compared to the average age of 24, [50] having more children (about 7% lowered risk per child), and breastfeeding (4.3% per breastfeeding year, with an average relative risk around 0.7 [51] [52]) have all been correlated to lowered breast cancer risk in premenopausal women, but not postmenopausal women, in large ...
The Nottingham prognostic index (NPI) is used to determine prognosis following surgery for breast cancer. [1] [2] Its value is calculated using three pathological criteria: the size of the tumour; the number of involved lymph nodes; and the grade of the tumour. [1] It is calculated to select patients for adjuvant treatment.
Ecsaine. Ultrasuede is the trade name for a synthetic ultra-microfiber fabric invented in 1970 by Dr. Miyoshi Okamoto, a scientist working for Toray Industries.In Japan, it is sold under the brand name Ecsaine. [1]